(6) performed a large study including 1,974 patients with RA and found higher levels of serum IgG anti-RgpB in ACPA-positive RA compared to ACPA-negative RA, with median levels of 231 AU/ml vs. 166 AU/ml. This evidence concerns the gene PRTN3 and rheumatoid arthritis.